Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ATOSSA THERAPEUTICS, INC. | President & CEO, Director | Stock Option (right to buy) | 1.8M | Jun 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATOS | ATOSSA THERAPEUTICS, INC. | Jun 27, 2024 | 1 | $0 | 4 | Jul 1, 2024 | President & CEO, Director |
ATOS | ATOSSA THERAPEUTICS, INC. | Mar 2, 2023 | 1 | $0 | 4 | Mar 6, 2023 | President & CEO, Director |
ATOS | ATOSSA THERAPEUTICS, INC. | Feb 24, 2022 | 1 | $0 | 4 | Feb 28, 2022 | President & CEO, Director |
ATOS | ATOSSA THERAPEUTICS, INC. | May 14, 2021 | 1 | $0 | 4 | May 18, 2021 | President & CEO, Director |
ATOS | ATOSSA THERAPEUTICS, INC. | May 14, 2021 | 1 | $0 | 4 | May 18, 2021 | President & CEO, Director |